Novel nano-carriers with N-formylmethionyl-leucyl-phenylalanine-modified liposomes improve effects of C16-angiopoietin 1 in acute animal model of multiple sclerosis

Combined treatment with C16 peptide and angiopoietin-1 confers neuroprotection and reduces inflammation in 3-nitropropionic acid-induced dystonia mice

(2021) Xiao-Xiao Fu et al.   Aging-US

CD47 antibody blockade suppresses microglia-dependent phagocytosis and monocyte transition to macrophages, impairing recovery in EAE

(2021) Huan Wang et al.   JCI Insight

Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease

(2021) Hua-Ying Cai et al.   npj Parkinsons Disease

Cytokines and Chemokines in the Pathogenesis of Experimental Autoimmune Encephalomyelitis

(2020) William J. Karpus   JOURNAL OF IMMUNOLOGY

Neurons promote encephalitogenic CD4+ lymphocyte infiltration in experimental autoimmune encephalomyelitis

(2020) Yuki Nakazato et al.   Scientific Reports

C16 peptide and angiopoietin-1 protect against LPS-induced BV-2 microglial cell inflammation

(2020) Xiaoxiao Fu et al.   LIFE SCIENCES

Gefitinib encapsulation based on nano-liposomes for enhancing the curative effect of lung cancer

(2020) Yanjie Hu et al.   CELL CYCLE

C16 Peptide Promotes Vascular Growth and Reduces Inflammation in a Neuromyelitis Optica Model

(2019) Haohao Chen et al.   Frontiers in Pharmacology

The contribution of neutrophils to CNS autoimmunity

(2018) Emily R. Pierson et al.   CLINICAL IMMUNOLOGY

Angiopoietin-1 and ανβ3 integrin peptide promote the therapeutic effects of L-serine in an amyotrophic lateral sclerosis/Parkinsonism dementia complex model

(2018) Hua-ying Cai et al.   Aging-US

Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation

(2017) Suzanne A. B. M. Aarts et al.   Journal of Neuroinflammation

Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis

(2016) Beibei Wang et al.   CNS & Neurological Disorders-Drug Targets

Angiotensin-(1-7) Attenuates Angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-κB Pathways in HUVECs

(2015) Bin Liang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis

(2014) Hong Jiang et al.   EXPERIMENTAL NEUROLOGY

Liposomes formulated with fMLP-modified cholesterol for enhancing drug concentration at inflammatory sites

(2014) Yao Qin et al.   JOURNAL OF DRUG TARGETING

Dose-Dependent Anti-Inflammatory and Neuroprotective Effects of anανβ3 Integrin-Binding Peptide

(2013) Shu Han et al.   MEDIATORS OF INFLAMMATION

C16 peptide shown to prevent leukocyte infiltration and alleviate detrimental inflammation in acute allergic encephalomyelitis model

(2013) Marong Fang et al.   NEUROPHARMACOLOGY

Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation

(2012) Pieter J. Gaillard et al.   JOURNAL OF CONTROLLED RELEASE

Rescuing vasculature with intravenous angiopoietin-1 and  v 3 integrin peptide is protective after spinal cord injury

(2010) S. Han et al.   BRAIN

Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice

(2010) Xiaomeng Ma et al.   PLoS One

Neurodegeneration in autoimmune CNS inflammation

(2009) Josephine Herz et al.   EXPERIMENTAL NEUROLOGY

Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate

(2009) Ruth Arnon et al.   JOURNAL OF NEURAL TRANSMISSION